Andrew Arnold

1.8k total citations
14 papers, 1.4k citations indexed

About

Andrew Arnold is a scholar working on Oncology, Molecular Biology and Nephrology. According to data from OpenAlex, Andrew Arnold has authored 14 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Molecular Biology and 5 papers in Nephrology. Recurrent topics in Andrew Arnold's work include Pancreatic and Hepatic Oncology Research (6 papers), Parathyroid Disorders and Treatments (5 papers) and Genetic Syndromes and Imprinting (4 papers). Andrew Arnold is often cited by papers focused on Pancreatic and Hepatic Oncology Research (6 papers), Parathyroid Disorders and Treatments (5 papers) and Genetic Syndromes and Imprinting (4 papers). Andrew Arnold collaborates with scholars based in United States, France and Italy. Andrew Arnold's co-authors include Toru Motokura, Lawrence Zukerberg, A. Bale, Carol L. Rosenberg, Nancy L. Harris, Emily Wong, Elizabeth M. Petty, Yuji Tsujimoto, Eric D. Hsi and Wookyeom Yang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Gastroenterology.

In The Last Decade

Andrew Arnold

14 papers receiving 1.4k citations

Peers

Andrew Arnold
Mariwil G. Wong United States
Branca Cavaco Portugal
Karin Bink Germany
Matthew A. Nehs United States
Noreen Fulton United States
Tammy Price-Troska United States
Andrew Arnold
Citations per year, relative to Andrew Arnold Andrew Arnold (= 1×) peers Valeriano Leite

Countries citing papers authored by Andrew Arnold

Since Specialization
Citations

This map shows the geographic impact of Andrew Arnold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Arnold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Arnold more than expected).

Fields of papers citing papers by Andrew Arnold

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Arnold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Arnold. The network helps show where Andrew Arnold may publish in the future.

Co-authorship network of co-authors of Andrew Arnold

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Arnold. A scholar is included among the top collaborators of Andrew Arnold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Arnold. Andrew Arnold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Imanishi, Yasuo, Yoshitaka Hosokawa, Katsuhiko Yoshimoto, et al.. (2001). Primary hyperparathyroidism caused by parathyroid-targeted overexpression of cyclin D1 in transgenic mice. Journal of Clinical Investigation. 107(9). 1093–1102. 165 indexed citations
2.
Brown, Suzanne B., Nallasivam Palanisamy, Isidro B. Salusky, et al.. (2000). Vitamin D Receptor as a Candidate Tumor-Suppressor Gene in Severe Hyperparathyroidism of Uremia1. The Journal of Clinical Endocrinology & Metabolism. 85(2). 868–872. 27 indexed citations
3.
Brown, SB, et al.. (1998). Overexpression of cyclin D1 protein in pancreatic endocrine tumors. Gastroenterology. 114. A448–A448. 1 indexed citations
4.
Chung, Daniel C., Alison Smith, David N. Louis, et al.. (1997). Analysis of the retinoblastoma tumour suppressor gene in pancreatic endocrine tumours. Clinical Endocrinology. 47(5). 523–528. 38 indexed citations
5.
Tahara, Hideki, Alison Smith, Randall D. Gaz, et al.. (1997). Parathyroid Tumor Suppressor on 1p: Analysis of the p18 Cyclin-Dependent Kinase Inhibitor Gene As a Candidate. Journal of Bone and Mineral Research. 12(9). 1330–1334. 30 indexed citations
6.
Hosokawa, Yoshitaka & Andrew Arnold. (1996). Cyclin D1/PRAD1 as a central target in oncogenesis. Journal of Laboratory and Clinical Medicine. 127(3). 246–252. 34 indexed citations
7.
Hsi, Eric D., Lawrence Zukerberg, Wookyeom Yang, & Andrew Arnold. (1996). Cyclin D1/PRAD1 expression in parathyroid adenomas: an immunohistochemical study.. The Journal of Clinical Endocrinology & Metabolism. 81(5). 1736–1739. 149 indexed citations
8.
Arnold, Andrew. (1995). The cyclin D1/PRAD1 oncogene in human neoplasia.. PubMed. 43(6). 543–9. 34 indexed citations
9.
Zukerberg, Lawrence, Woo Ick Yang, Michele A. Gadd, et al.. (1995). Cyclin D1 (PRAD1) protein expression in breast cancer: approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene.. PubMed. 8(5). 560–7. 106 indexed citations
10.
Motokura, Toru & Andrew Arnold. (1993). PRAD1/lCyclin D1 proto‐oncogene: Genomic organization, 5′ dna sequence, and sequence of a tumor‐specific rearrangement breakpoint. Genes Chromosomes and Cancer. 7(2). 89–95. 136 indexed citations
11.
Motokura, Toru & Andrew Arnold. (1993). Cyclin D and oncogenesis. Current Opinion in Genetics & Development. 3(1). 5–10. 204 indexed citations
12.
Arnold, Andrew. (1993). Genetic basis of endocrine disease 5. Molecular genetics of parathyroid gland neoplasia.. The Journal of Clinical Endocrinology & Metabolism. 77(5). 1108–1112. 43 indexed citations
13.
Rosenberg, Carol L., Emily Wong, Elizabeth M. Petty, et al.. (1991). PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma.. Proceedings of the National Academy of Sciences. 88(21). 9638–9642. 358 indexed citations
14.
Friedman, Eitan, Stephen J. Marx, Jeffrey A. Norton, et al.. (1990). Genetic Abnormalities in Sporadic Parathyroid Adenomas. The Journal of Clinical Endocrinology & Metabolism. 71(2). 293–297. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026